Premedication by thienopyridine before percutaneous coronary interventions in unstable angina;Prémédication par thiénopyridines avant angioplastie coronaire dans l'angor instable

Annales de Cardiologie et d'Angeiologie

Volumn 52, Issue 3, 2003, Pages 169-172

  Blanchard, D ^a   Demicheli, T ^b   Danchin, N ^b  

^a Clinique Saint Gatien   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Clopidogrel; Percutaneous coronary angioplasty; Stent; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; THIENO[2,3 B]PYRIDINE DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ARTICLE; CORONARY BLOOD VESSEL; DEVICE; DRUG EFFECT; FEMALE; HEART INFARCTION; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREMEDICATION; Q WAVE; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0038389688     PISSN: 00033928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-3928(03)00068-4     Document Type: Article

References (12)

1. Barragan P, Sainsous J, Silvestri M, Bouvier JL, Comet B, Simeoni JB, et al. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994 jun:32(2):133-8.
2. Morice MC, Zemour G, Benveniste E, Biron Y, Bourdonnec C, Faivre R, et al. Intracoronary stenting without coumadin: one month results of a french multicenter study. Cathet Cardiovasc Diagn 1995 may;35(1):1-7.
3. Karrillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. Thirty-days clinical outcome of the French Multicenter Registry. Circulation 1996 oct 1;94(7):1519-27.
4. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996 apr 25;334(17):1084-9.
5. Blanchard D, Lablanche JM. Report on interventional coronary cardiology in France. Angiography and Interventional Cardiology Group of the French Society of Cardiology. Arch Mal Coeur Vaiss 2000 feb;93(2):159-66.
6. Le Toumeau T, Blanchard D, Lablanche JM, Monassier JP, Morice MC, Cribier A, et al. Evolution of interventional cardiology in France during the last decade(1991-2000). Arch Mal Coeur Vaiss 2002 dec:95(12):1188-94 French.
7. Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH, Investigators FT. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (Classics). Circulation 2000 aug 8;102(6):624-9.
8. Steinhubl SR, Berger PB, Mann 3rd JT, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Jama 2002 nov 20;288(19):2411-20.
9. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-Cure study. Lancet 2001 aug 18;358 (9281):527-33.
10. Bhatt DL, Bertrand ME, Berger PB, L'Allier PL, Moussa I, Moses JW, et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002 jan 2;39(1):9-14.
11. Mueller C, Roskamm H, Neumann FJ, Hunziker P, Marsch S, Perruchoud A, et al. A randomized comparison of clopidogrel and aspirin vs ticlopidine and aspirin after the placement of coronary artery stents. J Am Coll Cardiol 2003 mar 19;41(6):969-73.
12. Chew DP, Bhatt DL, Robbins MA, Mukherjee D, Roffi M, Schneider JP, et al. Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. Am J Cardiol 2001 sep 15;88(6):672-4.